Related Experiment Videos
[Nasal decongestion evaluated by acoustic rhinometry]
Nihon Jibiinkoka Gakkai Kaiho
|November 1, 1994
Summary
Nasal decongestion from adrenergic agents is likely due to direct alpha-1 receptor activation. Drug particles conveyed by ciliary movement and sensory nerve activation also play roles in nasal volume changes.
Area of Science:
- Rhinology
- Pharmacology
- Acoustic Physiology
Context:
- Acoustic rhinometry non-invasively assesses nasal cavity cross-sectional area and volume.
- Understanding nasal mucosal decongestion mechanisms is crucial for respiratory health.
- Vasoactive agents and receptor antagonists were used to probe nasal responses.
Purpose:
- To investigate the mechanisms of nasal mucosal decongestion induced by various vasoactive agents.
- To differentiate the roles of direct receptor activation, ciliary transport, and neural pathways in nasal response.
- To analyze volume changes in different nasal cavity portions following topical agent application.
Summary:
- Topical phenylephrine and oxymetazoline caused immediate anterior nasal decongestion, extending posteriorly, while epinephrine initially decongested then congested the ipsilateral nasal cavity.
- Alpha-1 antagonists significantly inhibited phenylephrine/oxymetazoline-induced decongestion, and lidocaine abolished decongestion in middle/posterior portions and contralateral congestion.
- Findings suggest alpha-1 receptor activation drives decongestion, ciliary movement transports drugs to posterior areas, and contralateral responses involve ipsilateral sensory nerves.
Impact:
- Provides evidence that alpha-1 receptor activation is the primary mechanism for adrenergic nasal decongestion.
- Highlights the role of ciliary transport in drug distribution and effect within the nasal cavity.
- Suggests a neural basis for contralateral nasal responses to topical decongestants.